N

Nagendiran

Active Director Director DIN 07420631
DIN 07420631 First appointment Feb 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2016
Shareholding value Locked Premium profile

About Nagendiran

Data last updated:

Nagendiran has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Lipotek Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07420631
Primary Designation Director
First Appointment 17 Feb 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Director17 Feb 20162016Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lipotek Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nagendiran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagendiran

Nagendiran has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Lipotek Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Nagendiran is associated with 1 company as Director.

Nagendiran has expertise in General Business.

Nagendiran has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available